NCT07047482

Clinicopathological Value of p16 Expression in Colorectal Carcinoma

Clinicopathological Value of p16 Expression in Colorectal Carcinoma: An Immunohistochemical Study.

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 50 (estimated)
• Sponsor: Sohag University · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Evaluation of the immunohistochemical expression of p16 in colorectal carcinoma and correlate its expression to different clinical and pathological parameters as patients' ages, sexes, tumor location, histopathological phenotype, status of nodal involvement, perineural and lymphovascular invasion.

Detailed description

Colorectal Carcinoma is very common nowadays, with increasing need for further research. p16 is tumor suppressor gene with a vital rule ; inactivation of p16 leads to tumor formation and progression. 50 Specimens will be collected from Pathology Department of Sohag University Hospital. Sufficient clinical and histopathological data will be attached for each case. The previously processed formalin-fixed, paraffin-embedded tissue blocks will be used to get Hematoxylin \& Eosin stained sections to confirm the diagnosis and to detect the histopathological type, grade and stage of each tumor. Another sliced tissue sections will be immunohistochemically stained with p16 monoclonal antibodies to be evaluated with the positivity, intensity and distribution of the detected stain.

Conditions

• Colorectal Carcinoma

Interventions

Type	Name	Description
BIOLOGICAL	Immunohistochemical staining	Immunohistochemical staining of paraffin embedded blocks of colorectal carcinoma tissues by p16 monoclonal antibodies to be evaluated with the positivity, intensity and distribution of the detected stain.

Timeline

• Start date: 2025-05-01
• Primary completion: 2026-03-21
• Completion: 2026-12-30
• First posted: 2025-07-02
• Last updated: 2025-07-10

Locations

1 site across 1 country: Egypt